In a first-of-its-kind clinical trial, a human has received a 3D-bioprinted ear implant grown from the patient’s own living cells – thanks to a technology platform developed by a Cornellian-founded startup company.
A dozen graduating ROTC seniors were among 19 members of Cornell's Tri-Service Brigade who earned commissions in the Army, Navy, Air Force and Marines during a May 27 ceremony in Alice Statler Auditorium.
The team created and tested a new imaging approach which integrates information about where objects might be located with sonar processing algorithms that decide the optimal views.
The discovery made by two doctoral students could have future implications for human health, setting a path for research into understanding brain function.
Cornell researchers designed a micro-sized artificial cilial system that could eventually enable low-cost, portable diagnostic devices for testing blood samples, manipulating cells or assisting in microfabrication processes.
Cornell startup Antithesis Foods and Bactana were awarded NSF small-business grants, as Guard Medical raises $11 million in Series B investments and C2i launches a disease test in Europe.
Through their work on the dynamics of liquid mixtures, scientists have developed a new approach to the problem of cleaning sensitive, electronic surfaces.
Scientists soon will see Earth’s atmospheric dust in high-resolution, thanks to new spectrometer expected to launch June 7 aboard a SpaceX rocket to the International Space Station.
Researchers at CHESS examine proteins that reveal new ways to fight cancer, battery cells that enable a charge far beyond current capabilities and structural materials that enable space travel to improve with lightweight, yet more structurally sound components.